Balchem Corporation (BCPC) Income Statement
An income statement shows a company's revenue, expenses, and profit over a reporting period.
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide.
Total Revenue Chart for Balchem Corporation
Balchem Corporation (BCPC) revenue for FY2025 was USD 1.0B, a 8.8% change from FY2024. Balchem Corporation's revenue grew from USD 5.2M in 1985 to USD 1.0B in 2025 (19845.4% over 40 years). Earnings per share grew from USD 0.15 in 2000 to USD 3.25 in 2022 (2011.2%). Revenue compound annual growth rate: 5-year CAGR of 8.1%, 10-year CAGR of 6.5%, 20-year CAGR of 1.1%.
Total Revenue (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $5.64B
- Implied Share Price
- $177.00
- Enterprise Value
- $5.39B
- Revenue (TTM)
- $1.09B
- EBITDA
- $269.41M
- Profit Margin
- 15.14%
- Trailing P/E
- 34.84
- Forward P/E
- 29.33
- Price/Book (MRQ)
- 4.12
- Price/Sales (TTM)
- 5.20
- EV/EBITDA
- 20.34
- EV/Revenue
- 5.04
- Dividend Yield
- 0.55%
- Book Value
- $40.76
- Free Cash Flow (FY2025)
- $173.07M
- Free Cash Flow Yield
- 3.07%
Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.